Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M72,030Revenue $M6,932Net Margin (%)26.9Z-Score16.2
Enterprise Value $M71,369EPS $7.8Operating Margin %36.3F-Score7
P/E(ttm))37.9Cash Flow Per Share $7.4Pre-tax Margin (%)35.8Higher ROA y-yY
Price/Book7.810-y EBITDA Growth Rate %25.7Quick Ratio1.8Cash flow > EarningsY
Price/Sales9.45-y EBITDA Growth Rate %20.1Current Ratio2.2Lower Leverage y-yY
Price/Cash Flow20.5y-y EBITDA Growth Rate %38.8ROA % (ttm)15.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)21.6Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M237ROI % (ttm)19.7Gross Margin Increase y-yN

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBJoel Greenblatt 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 303.67-4%New holding, 3931 sh.3,931
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 303.67-4%New holding, 7500 sh.7,500
BIIBRon Baron 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 303.67-4%New holding, 6089 sh.6,089
BIIBJohn Burbank 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 303.67-4%New holding, 783 sh.783
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 303.67-4%Reduce -32.19%599,400
BIIBRay Dalio 2014-03-31 Sold Out -0.04%$273.518 - $351.94
($316.4)
$ 303.67-4%Sold Out0
BIIBRay Dalio 2013-12-31 Add0.03%$223.85 - $295.88
($258.53)
$ 303.6718%Add 208.67%19,057
BIIBJohn Hussman 2013-12-31 Sold Out -0.99%$223.85 - $295.88
($258.53)
$ 303.6718%Sold Out0
BIIBVanguard Health Care Fund 2013-12-31 Reduce-0.47%$223.85 - $295.88
($258.53)
$ 303.6718%Reduce -39.09%884,000
BIIBJohn Hussman 2013-09-30 Add0.33%$206.53 - $248.13
($223.63)
$ 303.6736%Add 50%75,000
BIIBMario Gabelli 2013-09-30 Add$206.53 - $248.13
($223.63)
$ 303.6736%Add 81.87%3,310
BIIBRay Dalio 2013-09-30 Reduce-0.01%$206.53 - $248.13
($223.63)
$ 303.6736%Reduce -41.27%6,174
BIIBFrank Sands 2013-06-30 Add0.71%$192.77 - $240.86
($213.68)
$ 303.6742%Add 27.6%4,565,921
BIIBMario Gabelli 2013-06-30 Reduce$192.77 - $240.86
($213.68)
$ 303.6742%Reduce -25.1%1,820
BIIBJohn Hussman 2013-06-30 Reduce-1.45%$192.77 - $240.86
($213.68)
$ 303.6742%Reduce -80.62%50,000
BIIBPRIMECAP Management 2013-06-30 Reduce-0.28%$192.77 - $240.86
($213.68)
$ 303.6742%Reduce -5%18,246,809
BIIBRay Dalio 2013-06-30 Reduce-0.07%$192.77 - $240.86
($213.68)
$ 303.6742%Reduce -78.85%10,512
BIIBFrank Sands 2013-03-31 Buy 2.4%$142.82 - $192.618
($161.38)
$ 303.6788%New holding, 3578308 sh.3,578,308
BIIBRay Dalio 2013-03-31 Add0.06%$142.82 - $192.618
($161.38)
$ 303.6788%Add 172.25%49,712
BIIBJohn Hussman 2013-03-31 Reduce-0.92%$142.82 - $192.618
($161.38)
$ 303.6788%Reduce -48.4%258,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BIIB Ron Baron 2014-03-316,08900.01New Buy
BIIB George Soros 2014-03-317,50000.02New Buy
BIIB Joel Greenblatt 2014-03-313,93100.02New Buy
BIIB John Burbank 2014-03-3178300.01New Buy
BIIB Frank Sands 2014-03-314,873,0172.053.9+2.5%
BIIB PRIMECAP Management 2014-03-3117,502,1067.386.1-1.55%
BIIB Mario Gabelli 2014-03-313,58500.01-3.37%
BIIB Vanguard Health Care Fund 2014-03-31599,4000.250.52-32.19%
BIIB Ray Dalio 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCANGOS GEORGE ACEO 2014-07-16Sell12,316$312.37-2.79view
Posner Brian SDirector 2014-06-20Sell605$315-3.6view
Posner Brian SDirector 2014-06-13Sell700$310.5-2.2view
SCANGOS GEORGE ACEO 2014-06-02Sell484$318.93-4.78view
Holtzman Steven HEVP Corporate Development 2014-05-19Sell1,221$289.155.02view
SCANGOS GEORGE ACEO 2014-05-01Sell2,123$285.566.34view
Holtzman Steven HEVP Corporate Development 2014-04-17Sell1,221$2914.35view
SCANGOS GEORGE ACEO 2014-04-01Sell2,123$308.42-1.54view
PANGIA ROBERT WDirector 2014-04-01Sell6,250$308.42-1.54view
Posner Brian SDirector 2014-03-31Sell3,000$296.762.33view

Press Releases about BIIB :

Quarterly/Annual Reports about BIIB:

News about BIIB:

Articles On GuruFocus.com
Ken Fisher's Top Increases of the First Quarter Apr 22 2014 
Weekly 52-Week Highs Highlight: ORLY, LLL, BIIB, NVS Feb 09 2014 
Weekly CFO Sells Highlight: CSOD, UTX, MEMS, SBAC, BIIB Sep 22 2013 
PRIMECAP Trims Top Biotechs and More Aug 30 2013 
Edward Owens’ Vanguard Health Care Fund Does More Shedding than Adding in Third Quarter Nov 01 2012 
52-Week High Guru Stocks: BIIB, GE, BDX, IR, PFE Sep 24 2012 
Weekly Top Insider Sells: GOOG, FIS, ORCL, and BIIB Aug 06 2012 
Spectrum: Allos Acquisition Means Huge Upside Potential May 04 2012 
Bearish John Hussman Sold Heavily in the First Quarter; New Portfolio Update May 02 2012 
Questcor: A Highly Shorted Stock To Watch This Year Apr 14 2012 


More From Other Websites
Will Biogen Idec Inc. (BIIB) Surprise this Earnings Season? Jul 22 2014
Alexion, 3 Other Top Biotechs Reporting Earnings Jul 22 2014
Is a Surprise Coming for Biogen Idec (BIIB) This Earnings Season? Jul 22 2014
Oil Dominates; Keurig, Constellation Near Buy Points Jul 21 2014
Biogen Shares Rebound As Street Has A Change Of Heart Jul 21 2014
Evaluating Biogen Idec After The Sell-Off Jul 21 2014
bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% Jul 21 2014
Top Biotech Earnings Previews for the Week Ahead Jul 20 2014
Politics fade as earnings take over Jul 18 2014
Baxter Q2 Earnings Beat Estimates, But Guidance Soft Jul 17 2014
Yellen Fire In The Biotech Theater Jul 17 2014
Ligand Pharmaceuticals (LGND) in Focus: Stock Falls 6.7% Jul 17 2014
Arena Pharmaceuticals' Pain Candidate Gets New U.S. Patent Jul 16 2014
Biogen Idec and Yahoo Health Spotlight Visionaries Whose Work Benefits People with Multiple... Jul 16 2014
CVS Caremark to Expand with Navarro Discount Pharmacy Buyout Jul 15 2014
3 Stocks Reiterated As A Buy: WMT, CMCSA, BIIB Jul 15 2014
Exelixis (EXEL) Soars: Stock Adds 23% in Session Jul 15 2014
IBD Big Cap 20 Leaders Hold Up Well Despite Shaky Market Jul 14 2014
Stocks Close Higher As Biotech, Internet Stocks Gain Jul 11 2014

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide